Regulatory press release

Veloxis Pharmaceuticals A/S - admittance to trading and official listing of new shares due to exercise of employee warrants

Nasdaq Copenhagen A/S
Equity Market information

Veloxis Pharmaceuticals A/S - admittance to trading and official listing of new
shares due to exercise of employee warrants

The share capital of Veloxis Pharmaceuticals has been increased. The admittance
to trading and official listing of new shares will take effect on 7 June 2019
in the ISIN below. 





ISIN:                  DK0060048148                             
----------------------------------------------------------------
Name:                  Veloxis Pharmaceuticals                  
----------------------------------------------------------------
Volume before change:  1,727,157,632 shares (DKK 172,715,763.20)
----------------------------------------------------------------
Change:                2,671,925 shares (DKK 267,192.50)        
----------------------------------------------------------------
Volume after change:   1,729,829,557 (DKK 172,982,955.70)       
----------------------------------------------------------------
Subscription price:    ·         DKK 0.35 - 1,472,857 shares    
                       ·         DKK 0.94 - 1,199,068 shares    
----------------------------------------------------------------
Denomination:          DKK 0.10                                 
----------------------------------------------------------------
Short name:            VELO                                     
----------------------------------------------------------------
Orderbook ID:                                              36992
----------------------------------------------------------------





For further information, please contact: Asta Jepsen, Surveillance, tel. +45 33
93 34 60